Works by Katayama, Masaki


Results: 46
    1
    2

    Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritis.

    Published in:
    Rheumatology, 2025, v. 64, n. 5, p. 2395, doi. 10.1093/rheumatology/keae603
    By:
    • Nishimura, Nozomi;
    • Onishi, Akira;
    • Yamamoto, Wataru;
    • Nagai, Koji;
    • Shiba, Hideyuki;
    • Okita, Yasutaka;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Okano, Takaichi;
    • Ueda, Yo;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Yamada, Shinsuke;
    • Hashimoto, Motomu;
    • Maeda, Yuichi;
    • Onizawa, Hideo;
    • Fujii, Takayuki;
    • Murata, Koichi;
    • Murakami, Kosaku;
    • Tanaka, Masao
    Publication type:
    Article
    3

    Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study-.

    Published in:
    PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0194130
    By:
    • Ebina, Kosuke;
    • Hashimoto, Motomu;
    • Yamamoto, Wataru;
    • Ohnishi, Akira;
    • Kabata, Daijiro;
    • Hirano, Toru;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Yoshida, Shuzo;
    • Nagai, Koji;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Akashi, Kengo;
    • Fujimura, Takanori;
    • Hirao, Makoto;
    • Yamamoto, Keiichi;
    • Shintani, Ayumi;
    • Kumanogoh, Atsushi;
    • Yoshikawa, Hideki
    Publication type:
    Article
    4

    Prognostic factors affecting respiratory-related death in patients with rheumatoid arthritis complicated by interstitial lung disease: An ANSWER cohort study.

    Published in:
    Modern Rheumatology, 2023, v. 33, n. 5, p. 928, doi. 10.1093/mr/roac115
    By:
    • Hidehiko Makino;
    • Kotani, Takuya;
    • Hata, Kenichiro;
    • Nishioka, Daisuke;
    • Yamamoto, Wataru;
    • Yoshikawa, Ayaka;
    • Wada, Yumiko;
    • Hiramatsu, Yuri;
    • Shiba, Hideyuki;
    • Nagai, Koji;
    • Katayama, Masaki;
    • Yonsu Son;
    • Amuro, Hideki;
    • Onishi, Akira;
    • Akashi, Kengo;
    • Hara, Ryota;
    • Hirano, Toru;
    • Hashimotoj, Motomu;
    • Takeuchia, Tohru
    Publication type:
    Article
    5

    Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort study.

    Published in:
    Modern Rheumatology, 2023, v. 33, n. 4, p. 690, doi. 10.1093/mr/roac092
    By:
    • Ebina, Kosuke;
    • Hirano, Toru;
    • Maeda, Yuichi;
    • Okita, Yasutaka;
    • Etani, Yuki;
    • Hirao, Makoto;
    • Yamamoto, Wataru;
    • Hashimoto, Motomu;
    • Murata, Koichi;
    • Onishi, Akira;
    • Jinno, Sadao;
    • Hara, Ryota;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Kotani, Takuya;
    • Shiba, Hideyuki;
    • Katayama, Masaki;
    • Yamamoto, Keiichi;
    • Kumanogoh, Atsushi;
    • Okada, Seiji
    Publication type:
    Article
    6

    The real-world effectiveness of anti-RANKL antibody denosumab on the clinical fracture prevention in patients with rheumatoid arthritis: The ANSWER cohort study.

    Published in:
    Modern Rheumatology, 2022, v. 32, n. 4, p. 834, doi. 10.1093/mr/roab043
    By:
    • Koichi Murata;
    • Ryuji Uozumi;
    • Motomu Hashimoto;
    • Kosuke Ebina;
    • Kengo Akashi;
    • Akira Onishi;
    • Koji Nagai;
    • Ayaka Yoshikawa;
    • Masaki Katayama;
    • Yonsu Son;
    • Hideki Amuro;
    • Ryota Hara;
    • Wataru Yamamoto;
    • Ryu Watanabe;
    • Kosaku Murakami;
    • Masao Tanaka;
    • Hiromu Ito;
    • Akio Morinobu;
    • Shuichi Matsuda
    Publication type:
    Article
    7
    8

    An Association Between Amino Acid Position 74 of HLA-DRB1 and Anti-Citrullinated Protein Antibody Levels in Japanese Patients With Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis.

    Published in:
    Arthritis & Rheumatology, 2015, v. 67, n. 8, p. 2038, doi. 10.1002/art.39133
    By:
    • Terao, Chikashi;
    • Suzuki, Akari;
    • Ikari, Katsunori;
    • Kochi, Yuta;
    • Ohmura, Koichiro;
    • Katayama, Masaki;
    • Nakabo, Shuichiro;
    • Yamamoto, Natsuki;
    • Suzuki, Taku;
    • Iwamoto, Takuji;
    • Yurugi, Kimiko;
    • Miura, Yasuo;
    • Maekawa, Taira;
    • Takasugi, Kiyoshi;
    • Kubo, Michiaki;
    • Saji, Hiroh;
    • Taniguchi, Atsuo;
    • Momohara, Shigeki;
    • Yamamoto, Kazuhiko;
    • Yamanaka, Hisashi
    Publication type:
    Article
    9

    Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-04075-0
    By:
    • Ebina, Kosuke;
    • Hirano, Toru;
    • Maeda, Yuichi;
    • Yamamoto, Wataru;
    • Hashimoto, Motomu;
    • Murata, Koichi;
    • Onishi, Akira;
    • Jinno, Sadao;
    • Hara, Ryota;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Takeuchi, Tohru;
    • Yoshikawa, Ayaka;
    • Katayama, Masaki;
    • Yamamoto, Keiichi;
    • Okita, Yasutaka;
    • Hirao, Makoto;
    • Etani, Yuki;
    • Kumanogoh, Atsushi;
    • Okada, Seiji
    Publication type:
    Article
    10
    11

    ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese.

    Published in:
    PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0040067
    By:
    • Terao, Chikashi;
    • Ohmura, Koichiro;
    • Ikari, Katsunori;
    • Kochi, Yuta;
    • Maruya, Etsuko;
    • Katayama, Masaki;
    • Yurugi, Kimiko;
    • Shimada, Kota;
    • Murasawa, Akira;
    • Honjo, Shigeru;
    • Takasugi, Kiyoshi;
    • Matsuo, Keitaro;
    • Tajima, Kazuo;
    • Suzuki, Akari;
    • Yamamoto, Kazuhiko;
    • Momohara, Shigeki;
    • Yamanaka, Hisashi;
    • Yamada, Ryo;
    • Saji, Hiroo;
    • Matsuda, Fumihiko
    Publication type:
    Article
    12

    Myelin Basic Protein as a Novel Genetic Risk Factor in Rheumatoid Arthritis--A Genome-Wide Study Combined with Immunological Analyses.

    Published in:
    PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0020457
    By:
    • Terao, Chikashi;
    • Ohmura, Koichiro;
    • Katayama, Masaki;
    • Takahashi, Meiko;
    • Kokubo, Miki;
    • Diop, Gora;
    • Toda, Yoshinobu;
    • Yamamoto, Natsuki;
    • Shinkura, Reiko;
    • Shimizu, Masakazu;
    • Gut, Ivo;
    • Heath, Simon;
    • Melchers, Inga;
    • Manabe, Toshiaki;
    • Lathrop, Mark;
    • Mimori, T. suneyo;
    • Yamada, Ryo;
    • Matsuda, Fumihiko
    Publication type:
    Article
    13
    14
    15
    16

    Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

    Published in:
    Arthritis & Rheumatology, 2020, v. 72, n. 3, p. 488, doi. 10.1002/art.41105
    By:
    • Tsuji, Hideaki;
    • Nakashima, Ran;
    • Hosono, Yuji;
    • Imura, Yoshitaka;
    • Yagita, Masato;
    • Yoshifuji, Hajime;
    • Hirata, Shintaro;
    • Nojima, Takaki;
    • Sugiyama, Eiji;
    • Hatta, Kazuhiro;
    • Taguchi, Yoshio;
    • Katayama, Masaki;
    • Tanizawa, Kiminobu;
    • Handa, Tomohiro;
    • Uozumi, Ryuji;
    • Akizuki, Shuji;
    • Murakami, Kosaku;
    • Hashimoto, Motomu;
    • Tanaka, Masao;
    • Ohmura, Koichiro
    Publication type:
    Article
    17
    18
    19
    20

    An Autopsy Case of Post-COVID-19 Interstitial Lung Disease with Acute Exacerbation.

    Published in:
    Internal Medicine, 2023, v. 62, n. 23, p. 3519, doi. 10.2169/internalmedicine.2006-23
    By:
    • Akifumi Tsuzuku;
    • Fumihiro Asano;
    • Masaki Katayama;
    • Kosuke Mori;
    • Yui Sasaki;
    • Yutaro Kuzunishi;
    • Mayuka Taguchi;
    • Yuya Muto;
    • Yasutomo Baba;
    • Akimasa Tsuchida;
    • Tomoya Kato;
    • Anri Murakami;
    • Atsunori Masuda;
    • Takashi Yoshizane;
    • Jun Suzuki
    Publication type:
    Article
    21
    22

    Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study.

    Published in:
    Arthritis Research & Therapy, 2021, v. 23, n. 1, p. 1, doi. 10.1186/s13075-021-02496-w
    By:
    • Jinno, Sadao;
    • Onishi, Akira;
    • Dubreuil, Maureen;
    • Hashimoto, Motomu;
    • Yamamoto, Wataru;
    • Murata, Koichi;
    • Takeuchi, Tohru;
    • Kotani, Takuya;
    • Maeda, Yuichi;
    • Ebina, Kosuke;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Saegusa, Jun
    Publication type:
    Article
    23

    Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study.

    Published in:
    Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1673-1
    By:
    • Hashimoto, Motomu;
    • Furu, Moritoshi;
    • Yamamoto, Wararu;
    • Fujimura, Takanori;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Ohnishi, Akira;
    • Akashi, Kengo;
    • Yoshida, Shuzo;
    • Nagai, Koji;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Hirano, Toru;
    • Ebina, Kosuke;
    • Uozumi, Ryuji;
    • Ito, Hiromu;
    • Tanaka, Masao;
    • Ohmura, Koichiro;
    • Fujii, Takao;
    • Mimori, Tsuneyo
    Publication type:
    Article
    24

    Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study-.

    Published in:
    PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216624
    By:
    • Ebina, Kosuke;
    • Hashimoto, Motomu;
    • Yamamoto, Wataru;
    • Hirano, Toru;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Onishi, Akira;
    • Nagai, Koji;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Yamamoto, Keiichi;
    • Maeda, Yuichi;
    • Murata, Koichi;
    • Jinno, Sadao;
    • Takeuchi, Tohru;
    • Hirao, Makoto;
    • Kumanogoh, Atsushi;
    • Yoshikawa, Hideki
    Publication type:
    Article
    25

    Association of large joint involvement at the start of biological disease‐modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study.

    Published in:
    International Journal of Rheumatic Diseases, 2024, v. 27, n. 3, p. 1, doi. 10.1111/1756-185X.15097
    By:
    • Shirasugi, Iku;
    • Onishi, Akira;
    • Nishimura, Keisuke;
    • Yamamoto, Wataru;
    • Murakami, Kosaku;
    • Onizawa, Hideo;
    • Maeda, Yuichi;
    • Ebina, Kosuke;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Katayama, Masaki;
    • Hara, Ryota;
    • Nagai, Koji;
    • Hiramatsu, Yuri;
    • Hashimoto, Motomu;
    • Okano, Tadashi;
    • Maeda, Toshihisa;
    • Hayashi, Shinya;
    • Sendo, Sho;
    • Jinno, Sadao
    Publication type:
    Article
    26

    Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study.

    Published in:
    International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7399, doi. 10.3390/ijms24087399
    By:
    • Shiba, Hideyuki;
    • Kotani, Takuya;
    • Nagai, Koji;
    • Hata, Kenichiro;
    • Yamamoto, Wataru;
    • Yoshikawa, Ayaka;
    • Wada, Yumiko;
    • Hiramatsu, Yuri;
    • Makino, Hidehiko;
    • Ueda, Yo;
    • Onishi, Akira;
    • Murata, Koichi;
    • Amuro, Hideki;
    • Son, Yonsu;
    • Hara, Ryota;
    • Hirano, Toru;
    • Ebina, Kosuke;
    • Katayama, Masaki;
    • Hashimoto, Motomu;
    • Takeuchi, Tohru
    Publication type:
    Article
    27
    28
    29
    30
    31

    Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort study.

    Published in:
    Clinical Rheumatology, 2021, v. 40, n. 7, p. 2673, doi. 10.1007/s10067-021-05609-7
    By:
    • Ebina, Kosuke;
    • Hirano, Toru;
    • Maeda, Yuichi;
    • Yamamoto, Wataru;
    • Hashimoto, Motomu;
    • Murata, Koichi;
    • Onishi, Akira;
    • Jinno, Sadao;
    • Hara, Ryota;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Takeuchi, Tohru;
    • Yoshikawa, Ayaka;
    • Katayama, Masaki;
    • Yamamoto, Keiichi;
    • Hirao, Makoto;
    • Okita, Yasutaka;
    • Kumanogoh, Atsushi;
    • Nakata, Ken
    Publication type:
    Article
    32

    Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study-.

    Published in:
    Clinical Rheumatology, 2020, v. 39, n. 9, p. 2563, doi. 10.1007/s10067-020-05015-5
    By:
    • Ebina, Kosuke;
    • Hirano, Toru;
    • Maeda, Yuichi;
    • Yamamoto, Wataru;
    • Hashimoto, Motomu;
    • Murata, Koichi;
    • Takeuchi, Tohru;
    • Nagai, Koji;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Onishi, Akira;
    • Jinno, Sadao;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Yamamoto, Keiichi;
    • Kumanogoh, Atsushi;
    • Hirao, Makoto
    Publication type:
    Article
    33
    34

    Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study.

    Published in:
    Rheumatology International, 2022, v. 42, n. 7, p. 1227, doi. 10.1007/s00296-021-05086-w
    By:
    • Nakayama, Yoichi;
    • Watanabe, Ryu;
    • Murakami, Kosaku;
    • Murata, Koichi;
    • Tanaka, Masao;
    • Ito, Hiromu;
    • Yamamoto, Wataru;
    • Ebina, Kosuke;
    • Hata, Kenichiro;
    • Hiramatsu, Yuri;
    • Katayama, Masaki;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Akashi, Kengo;
    • Onishi, Akira;
    • Hara, Ryota;
    • Yamamoto, Keiichi;
    • Ohmura, Koichiro;
    • Matsuda, Shuichi;
    • Morinobu, Akio
    Publication type:
    Article
    35

    Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.

    Published in:
    Rheumatology International, 2021, v. 41, n. 7, p. 1233, doi. 10.1007/s00296-021-04862-y
    By:
    • Maeda, Yuichi;
    • Hirano, Toru;
    • Ebina, Kosuke;
    • Hara, Ryota;
    • Hashimoto, Motomu;
    • Yamamoto, Wataru;
    • Murakami, Kosaku;
    • Kotani, Takuya;
    • Hata, Kenichiro;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Onishi, Akira;
    • Jinno, Sadao;
    • Katayama, Masaki;
    • Kumanogoh, Atsushi
    Publication type:
    Article
    36

    Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study.

    Published in:
    Rheumatology International, 2020, v. 40, n. 12, p. 1987, doi. 10.1007/s00296-020-04660-y
    By:
    • Jinno, Sadao;
    • Onishi, Akira;
    • Dubreuil, Maureen;
    • Akashi, Kengo;
    • Hashimoto, Motomu;
    • Yamamoto, Wataru;
    • Murata, Koichi;
    • Takeuchi, Tohru;
    • Kotani, Takuya;
    • Maeda, Yuichi;
    • Ebina, Kosuke;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Saegusa, Jun;
    • Morinobu, Akio
    Publication type:
    Article
    37

    The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study

    Published in:
    Rheumatology International, 2020, v. 40, n. 2, p. 217, doi. 10.1007/s00296-019-04464-9
    By:
    • Murata, Koichi;
    • Hashimoto, Motomu;
    • Yamamoto, Wataru;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Nagai, Koji;
    • Takeuchi, Tohru;
    • Katayama, Masaki;
    • Maeda, Yuichi;
    • Ebina, Kosuke;
    • Hara, Ryota;
    • Jinno, Sadao;
    • Onishi, Akira;
    • Murakami, Kosaku;
    • Tanaka, Masao;
    • Ito, Hiromu;
    • Mimori, Tsuneyo;
    • Matsuda, Shuichi
    Publication type:
    Article
    38

    Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study.

    Published in:
    Rheumatology, 2025, v. 64, n. 2, p. 509, doi. 10.1093/rheumatology/keae081
    By:
    • Jinno, Sadao;
    • Onishi, Akira;
    • Hattori, Shuhei;
    • Dubreuil, Maureen;
    • Ueda, Yo;
    • Nishimura, Keisuke;
    • Okano, Takaichi;
    • Yamada, Hirotaka;
    • Yamamoto, Wataru;
    • Murata, Koichi;
    • Onizawa, Hideo;
    • Ebina, Kosuke;
    • Maeda, Yuichi;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Hara, Ryota;
    • Hata, Kenichiro;
    • Shiba, Hideyuki;
    • Katayama, Masaki;
    • Watanabe, Ryu
    Publication type:
    Article
    39
    40

    Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study.

    Published in:
    Rheumatology, 2024, v. 63, n. 9, p. 2418, doi. 10.1093/rheumatology/keae265
    By:
    • Watanabe, Ryu;
    • Ebina, Kosuke;
    • Gon, Takaho;
    • Okano, Tadashi;
    • Murata, Koichi;
    • Murakami, Kosaku;
    • Maeda, Yuichi;
    • Jinno, Sadao;
    • Shirasugi, Iku;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Katayama, Masaki;
    • Hara, Ryota;
    • Hata, Kenichiro;
    • Yoshikawa, Ayaka;
    • Yamamoto, Wataru;
    • Tachibana, Shotaro;
    • Hayashi, Shinya;
    • Etani, Yuki;
    • Katsushima, Masao
    Publication type:
    Article
    41

    IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort study.

    Published in:
    Rheumatology, 2024, v. 63, n. 2, p. 349, doi. 10.1093/rheumatology/kead299
    By:
    • Nakayama, Yoichi;
    • Watanabe, Ryu;
    • Yamamoto, Wataru;
    • Ebina, Kosuke;
    • Hirano, Toru;
    • Kotani, Takuya;
    • Shiba, Hideyuki;
    • Katayama, Masaki;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Onishi, Akira;
    • Jinno, Sadao;
    • Hara, Ryota;
    • Murakami, Kosaku;
    • Murata, Koichi;
    • Ito, Hiromu;
    • Tanaka, Masao;
    • Matsuda, Shuichi;
    • Morinobu, Akio;
    • Hashimoto, Motomu
    Publication type:
    Article
    42

    Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis.

    Published in:
    Rheumatology, 2010, v. 49, n. 12, p. 2298, doi. 10.1093/rheumatology/keq273
    By:
    • Ohmura, Koichiro;
    • Terao, Chikashi;
    • Maruya, Etsuko;
    • Katayama, Masaki;
    • Matoba, Kenichiro;
    • Shimada, Kota;
    • Murasawa, Akira;
    • Honjo, Shigeru;
    • Takasugi, Kiyoshi;
    • Tohma, Shigeto;
    • Matsuo, Keitaro;
    • Tajima, Kazuo;
    • Yukawa, Naoichiro;
    • Kawabata, Daisuke;
    • Nojima, Takaki;
    • Fujii, Takao;
    • Yamada, Ryo;
    • Saji, Hiroo;
    • Matsuda, Fumihiko;
    • Mimori, Tsuneyo
    Publication type:
    Article
    43

    Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study.

    Published in:
    Arthritis Research & Therapy, 2020, v. 22, n. 1, p. 1, doi. 10.1186/s13075-020-02232-w
    By:
    • Ebina, Kosuke;
    • Hirano, Toru;
    • Maeda, Yuichi;
    • Yamamoto, Wataru;
    • Hashimoto, Motomu;
    • Murata, Koichi;
    • Takeuchi, Tohru;
    • Shiba, Hideyuki;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Onishi, Akira;
    • Akashi, Kengo;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Yamamoto, Keiichi;
    • Kumanogoh, Atsushi;
    • Hirao, Makoto
    Publication type:
    Article
    44

    Risk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross Hospital.

    Published in:
    Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-2053-1
    By:
    • Fukuda, Wataru;
    • Hanyu, Tadamasa;
    • Katayama, Masaki;
    • Mizuki, Shinichi;
    • Okada, Akitomo;
    • Miyata, Masayuki;
    • Handa, Yuichi;
    • Hayashi, Masatoshi;
    • Koyama, Yoshinobu;
    • Arii, Kaoru;
    • Kitaori, Toshiyuki;
    • Hagiyama, Hiroyuki;
    • Urushidani, Yoshinori;
    • Yamasaki, Takahito;
    • Ikeno, Yoshihiko;
    • Suzuki, Takeshi;
    • Omoto, Atsushi;
    • Sugitani, Toshifumi;
    • Morita, Satoshi;
    • Inokuma, Shigeko
    Publication type:
    Article
    45
    46

    Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study.

    Published in:
    Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1880-4
    By:
    • Ebina, Kosuke;
    • Hashimoto, Motomu;
    • Yamamoto, Wataru;
    • Hirano, Toru;
    • Hara, Ryota;
    • Katayama, Masaki;
    • Onishi, Akira;
    • Nagai, Koji;
    • Son, Yonsu;
    • Amuro, Hideki;
    • Yamamoto, Keiichi;
    • Maeda, Yuichi;
    • Murata, Koichi;
    • Jinno, Sadao;
    • Takeuchi, Tohru;
    • Hirao, Makoto;
    • Kumanogoh, Atsushi;
    • Yoshikawa, Hideki
    Publication type:
    Article